Viewing Study NCT01301300



Ignite Creation Date: 2024-05-05 @ 11:20 PM
Last Modification Date: 2024-10-26 @ 10:32 AM
Study NCT ID: NCT01301300
Status: UNKNOWN
Last Update Posted: 2011-02-23
First Post: 2011-02-22

Brief Title: Evaluating Central Line Hub Contamination Using a Novel Capping Device
Sponsor: NorthShore University HealthSystem
Organization: NorthShore University HealthSystem

Study Overview

Official Title: Demonstration of Central Line Hub Contamination Reduction Using a Novel Capping Device
Status: UNKNOWN
Status Verified Date: 2011-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Excelsior Medical has developed SwabCap a luer access valve disinfection cap The SwabCap provides passive disinfection of valve top and threads without activating the luer access valve This product promotes technique standardization and compliance in cleansing of the luer access valve prior to access It acts as a physical barrier from touch and airborne contamination for up to 96 hours This product has been endorsed and will be adopted for use at NorthShore University HealthSystem as a quality improvement initiative This research study protocol is designed to confirm the anticipated benefit of this change in practice at NorthShore during the planned implementation and use

If the product performs as it has been designed to the baseline rate of hub and subsequently intraluminal contamination will be diminished thereby protecting patients with central lines from bloodstream infections due to contaminated hubs
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None